Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.448NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.448NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.448NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.425NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.425NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.425NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.354NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.354NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.503NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.503NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.503NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.623NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.623NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.623NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.214.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.214.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.214.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.588NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.588NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.588NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.210NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.210NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.210NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.567NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.567NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.567NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.541NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.541NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.541NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.189NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.189NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used